MEDNAX, INC.·4

Feb 14, 4:32 PM ET

Clark David A. 4

4 · MEDNAX, INC. · Filed Feb 14, 2019

Insider Transaction Report

Form 4
Period: 2019-02-12
Clark David A.
COO / Pediatrix Division
Transactions
  • Award

    Common Stock

    2019-02-12+56,571143,416 total
Footnotes (1)
  • [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 14,143 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION